Intuitive Surgical, Inc. (ISRG)
USD 526.47
(-3.43%)
USD 526.47
(-3.43%)
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2023 | 15.44 Billion USD | 19.02% |
| 2022 | 12.97 Billion USD | -4.29% |
| 2021 | 13.55 Billion USD | 21.36% |
| 2020 | 11.16 Billion USD | 14.75% |
| 2019 | 9.73 Billion USD | 24.04% |
| 2018 | 7.84 Billion USD | 36.27% |
| 2017 | 5.75 Billion USD | -11.24% |
| 2016 | 6.48 Billion USD | 32.19% |
| 2015 | 4.9 Billion USD | 23.94% |
| 2014 | 3.95 Billion USD | 0.23% |
| 2013 | 3.95 Billion USD | -2.68% |
| 2012 | 4.05 Billion USD | 32.52% |
| 2011 | 3.06 Billion USD | 28.14% |
| 2010 | 2.39 Billion USD | 32.09% |
| 2009 | 1.8 Billion USD | 22.72% |
| 2008 | 1.47 Billion USD | 41.79% |
| 2007 | 1.03 Billion USD | 54.81% |
| 2006 | 671.79 Million USD | 33.93% |
| 2005 | 501.58 Million USD | 41.6% |
| 2004 | 354.22 Million USD | 12.46% |
| 2003 | 314.99 Million USD | 243.95% |
| 2002 | 91.58 Million USD | -8.75% |
| 2001 | 100.36 Million USD | -10.73% |
| 2000 | 112.42 Million USD | 226.28% |
| 1999 | 34.45 Million USD | 22.32% |
| 1998 | 28.16 Million USD | 0.0% |
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2024 Q2 | 16.64 Billion USD | 5.19% |
| 2024 Q1 | 15.82 Billion USD | 2.5% |
| 2024 Q3 | 17.74 Billion USD | 6.57% |
| 2023 Q3 | 14.71 Billion USD | 5.82% |
| 2023 Q4 | 15.44 Billion USD | 4.95% |
| 2023 FY | 15.44 Billion USD | 19.02% |
| 2023 Q1 | 13.05 Billion USD | 0.61% |
| 2023 Q2 | 13.9 Billion USD | 6.51% |
| 2022 FY | 12.97 Billion USD | -4.29% |
| 2022 Q3 | 13.26 Billion USD | -3.24% |
| 2022 Q1 | 13.67 Billion USD | 0.91% |
| 2022 Q4 | 12.97 Billion USD | -2.16% |
| 2022 Q2 | 13.7 Billion USD | 0.2% |
| 2021 Q1 | 11.54 Billion USD | 3.33% |
| 2021 FY | 13.55 Billion USD | 21.36% |
| 2021 Q2 | 12.29 Billion USD | 6.56% |
| 2021 Q3 | 12.93 Billion USD | 5.19% |
| 2021 Q4 | 13.55 Billion USD | 4.8% |
| 2020 Q1 | 9.89 Billion USD | 1.62% |
| 2020 Q4 | 11.16 Billion USD | 5.19% |
| 2020 Q3 | 10.61 Billion USD | 5.09% |
| 2020 Q2 | 10.1 Billion USD | 2.15% |
| 2020 FY | 11.16 Billion USD | 14.75% |
| 2019 Q4 | 9.73 Billion USD | 6.59% |
| 2019 Q3 | 9.13 Billion USD | 7.03% |
| 2019 FY | 9.73 Billion USD | 24.04% |
| 2019 Q1 | 8.23 Billion USD | 4.95% |
| 2019 Q2 | 8.53 Billion USD | 3.6% |
| 2018 Q4 | 7.84 Billion USD | 7.22% |
| 2018 FY | 7.84 Billion USD | 36.27% |
| 2018 Q1 | 6.42 Billion USD | 11.6% |
| 2018 Q2 | 6.84 Billion USD | 6.59% |
| 2018 Q3 | 7.31 Billion USD | 6.85% |
| 2017 Q1 | 4.8 Billion USD | -25.88% |
| 2017 Q4 | 5.75 Billion USD | 2.01% |
| 2017 Q3 | 5.64 Billion USD | 7.5% |
| 2017 Q2 | 5.25 Billion USD | 9.21% |
| 2017 FY | 5.75 Billion USD | -11.24% |
| 2016 Q4 | 6.48 Billion USD | 5.06% |
| 2016 Q2 | 5.78 Billion USD | 8.94% |
| 2016 Q1 | 5.3 Billion USD | 8.13% |
| 2016 FY | 6.48 Billion USD | 32.19% |
| 2016 Q3 | 6.17 Billion USD | 6.81% |
| 2015 Q3 | 4.68 Billion USD | 7.53% |
| 2015 Q4 | 4.9 Billion USD | 4.81% |
| 2015 Q1 | 4.12 Billion USD | 4.21% |
| 2015 FY | 4.9 Billion USD | 23.94% |
| 2015 Q2 | 4.35 Billion USD | 5.53% |
| 2014 Q3 | 3.65 Billion USD | 7.25% |
| 2014 Q1 | 4.19 Billion USD | 6.17% |
| 2014 Q4 | 3.95 Billion USD | 8.43% |
| 2014 FY | 3.95 Billion USD | 0.23% |
| 2014 Q2 | 3.4 Billion USD | -18.83% |
| 2013 Q4 | 3.95 Billion USD | 6.84% |
| 2013 Q3 | 3.69 Billion USD | -11.99% |
| 2013 Q2 | 4.2 Billion USD | -0.81% |
| 2013 Q1 | 4.23 Billion USD | 4.35% |
| 2013 FY | 3.95 Billion USD | -2.68% |
| 2012 FY | 4.05 Billion USD | 32.52% |
| 2012 Q4 | 4.05 Billion USD | 8.76% |
| 2012 Q3 | 3.73 Billion USD | 2.93% |
| 2012 Q2 | 3.62 Billion USD | 8.8% |
| 2012 Q1 | 3.33 Billion USD | 8.81% |
| 2011 Q3 | 2.74 Billion USD | 3.63% |
| 2011 Q1 | 2.56 Billion USD | 7.44% |
| 2011 FY | 3.06 Billion USD | 28.14% |
| 2011 Q4 | 3.06 Billion USD | 11.55% |
| 2011 Q2 | 2.64 Billion USD | 3.18% |
| 2010 Q3 | 2.35 Billion USD | 4.85% |
| 2010 FY | 2.39 Billion USD | 32.09% |
| 2010 Q4 | 2.39 Billion USD | 1.64% |
| 2010 Q2 | 2.24 Billion USD | 11.23% |
| 2010 Q1 | 2.01 Billion USD | 11.43% |
| 2009 Q1 | 1.38 Billion USD | -6.01% |
| 2009 Q4 | 1.8 Billion USD | 10.5% |
| 2009 FY | 1.8 Billion USD | 22.72% |
| 2009 Q3 | 1.63 Billion USD | 9.09% |
| 2009 Q2 | 1.5 Billion USD | 8.31% |
| 2008 FY | 1.47 Billion USD | 41.79% |
| 2008 Q4 | 1.47 Billion USD | 8.06% |
| 2008 Q3 | 1.36 Billion USD | 10.82% |
| 2008 Q2 | 1.23 Billion USD | 9.62% |
| 2008 Q1 | 1.12 Billion USD | 8.01% |
| 2007 Q1 | 724.16 Million USD | 7.8% |
| 2007 Q4 | 1.03 Billion USD | 14.0% |
| 2007 FY | 1.03 Billion USD | 54.81% |
| 2007 Q3 | 912.24 Million USD | 12.8% |
| 2007 Q2 | 808.69 Million USD | 11.67% |
| 2006 Q2 | 565.83 Million USD | 7.88% |
| 2006 FY | 671.79 Million USD | 33.93% |
| 2006 Q3 | 613.99 Million USD | 8.51% |
| 2006 Q4 | 671.79 Million USD | 9.41% |
| 2006 Q1 | 524.5 Million USD | 4.57% |
| 2005 Q3 | 427.91 Million USD | 9.86% |
| 2005 Q2 | 389.52 Million USD | 5.5% |
| 2005 Q1 | 369.2 Million USD | 4.23% |
| 2005 FY | 501.58 Million USD | 41.6% |
| 2005 Q4 | 501.58 Million USD | 17.22% |
| 2004 Q3 | 336.82 Million USD | 4.45% |
| 2004 FY | 354.22 Million USD | 12.46% |
| 2004 Q1 | 316.33 Million USD | 0.43% |
| 2004 Q4 | 354.22 Million USD | 5.17% |
| 2004 Q2 | 322.46 Million USD | 1.93% |
| 2003 Q4 | 314.99 Million USD | 31.93% |
| 2003 Q2 | 245.48 Million USD | 174.54% |
| 2003 Q1 | 89.41 Million USD | -2.36% |
| 2003 Q3 | 238.76 Million USD | -2.74% |
| 2003 FY | 314.99 Million USD | 243.95% |
| 2002 Q4 | 91.58 Million USD | -1.37% |
| 2002 Q2 | 93.53 Million USD | -2.05% |
| 2002 Q1 | 95.48 Million USD | -4.86% |
| 2002 FY | 91.58 Million USD | -8.75% |
| 2002 Q3 | 92.85 Million USD | -0.73% |
| 2001 Q2 | 103 Million USD | -1.91% |
| 2001 FY | 100.36 Million USD | -10.73% |
| 2001 Q4 | 100.36 Million USD | -0.05% |
| 2001 Q3 | 100.41 Million USD | -2.52% |
| 2001 Q1 | 105 Million USD | -6.6% |
| 2000 Q1 | 65.08 Million USD | 0.0% |
| 2000 Q4 | 112.42 Million USD | 1.22% |
| 2000 Q3 | 111.06 Million USD | 4.22% |
| 2000 Q2 | 106.57 Million USD | 63.75% |
| 2000 FY | 112.42 Million USD | 226.28% |
| 1999 FY | 34.45 Million USD | 22.32% |
| 1998 FY | 28.16 Million USD | 0.0% |
| Name | Total Assets | Total Assets Difference |
|---|---|---|
| Akoya Biosciences, Inc. | 180.36 Million USD | -8461.061% |
| AngioDynamics, Inc. | 317.67 Million USD | -4760.847% |
| AtriCure, Inc. | 613.93 Million USD | -2415.181% |
| Avinger, Inc. | 13.77 Million USD | -112038.707% |
| Azenta, Inc. | 2.88 Billion USD | -435.1% |
| BioLife Solutions, Inc. | 412.71 Million USD | -3641.453% |
| The Cooper Companies, Inc. | 11.65 Billion USD | -32.444% |
| Daxor Corporation | 34.86 Million USD | -44184.141% |
| Ekso Bionics Holdings, Inc. | 28.91 Million USD | -53297.538% |
| Femasys Inc. | 27.75 Million USD | -55533.367% |
| GlucoTrack, Inc. | 4.9 Million USD | -314711.417% |
| Harvard Bioscience, Inc. | 137.36 Million USD | -11141.137% |
| Hologic, Inc. | 9.15 Billion USD | -68.649% |
| ICU Medical, Inc. | 4.37 Billion USD | -252.671% |
| KORU Medical Systems, Inc. | 28.46 Million USD | -54154.999% |
| LeMaitre Vascular, Inc. | 346.77 Million USD | -4352.849% |
| Innovative Eyewear, Inc. | 6.21 Million USD | -248205.048% |
| Innovative Eyewear, Inc. | 6.21 Million USD | -248205.048% |
| Masimo Corporation | 3.04 Billion USD | -407.694% |
| Microbot Medical Inc. | 8.32 Million USD | -185338.934% |
| Meihua International Medical Technologies Co., Ltd. | 171.91 Million USD | -8882.041% |
| Merit Medical Systems, Inc. | 2.32 Billion USD | -564.081% |
| Nephros, Inc. | 11.86 Million USD | -130087.168% |
| NovoCure Limited | 1.14 Billion USD | -1247.274% |
| NEXGEL, Inc. | 9.95 Million USD | -155013.009% |
| NEXGEL, Inc. | 9.95 Million USD | -155013.009% |
| Singular Genomics Systems, Inc. | 265.46 Million USD | -5716.731% |
| OraSure Technologies, Inc. | 482.84 Million USD | -3098.024% |
| Pro-Dex, Inc. | 54.21 Million USD | -28384.597% |
| Pulse Biosciences, Inc. | 60.8 Million USD | -25295.533% |
| Predictive Oncology Inc. | 14.41 Million USD | -107004.344% |
| Precision Optics Corporation, Inc. | 16.91 Million USD | -91201.892% |
| QuidelOrtho Corporation | 8.56 Billion USD | -80.326% |
| Repligen Corporation | 2.82 Billion USD | -446.716% |
| Sanara MedTech Inc. | 73.87 Million USD | -20803.289% |
| STAAR Surgical Company | 488.69 Million USD | -3059.761% |
| Sharps Technology, Inc. | 11.78 Million USD | -130879.294% |
| Utah Medical Products, Inc. | 135.45 Million USD | -11299.474% |
| DENTSPLY SIRONA Inc. | 7.37 Billion USD | -109.518% |
| Jin Medical International Ltd. | 32.9 Million USD | -46829.729% |